{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:18:44Z","timestamp":1785802724551,"version":"3.56.0"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,9,1]]},"DOI":"10.1093\/jac\/dku135","type":"journal-article","created":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T04:07:57Z","timestamp":1400558877000},"page":"2547-2555","source":"Crossref","is-referenced-by-count":4,"title":["Quantifying the matrix of relationships between reduced vancomycin susceptibility phenotypes and outcomes among patients with MRSA bloodstream infections treated with vancomycin\u00a0"],"prefix":"10.1093","volume":"69","author":[{"given":"T. P.","family":"Lodise","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. L.","family":"Drusano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Lazariu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"El-Fawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Graffunder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Stellrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. E.","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. N.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Cosler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. A.","family":"McNutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,5,19]]},"reference":[{"key":"key\n\t\t\t\t20170425171834_DKU135C1","volume-title":"Performance Standards for Antimicrobial Disk Susceptibility Tests\u2014Ninth Edition: Approved Standard M2-M9","author":"Clinical and Laboratory Standards Institute","year":"2006"},{"key":"key\n\t\t\t\t20170425171834_DKU135C2","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1086\/423145","article-title":"Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein","volume":"190","year":"2004","journal-title":"J Infect Dis"},{"issue":"Suppl 5","key":"key\n\t\t\t\t20170425171834_DKU135C3","first-page":"S360","article-title":"Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains","volume":"46","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"key\n\t\t\t\t20170425171834_DKU135C4","first-page":"S40","article-title":"Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy","volume":"42","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425171834_DKU135C5","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1128\/AAC.00918-10","article-title":"Increased mortality with accessory gene regulator (agr) dysfunction in Staphylococcus aureus among bacteremic patients","volume":"55","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425171834_DKU135C6","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/cid\/cir935","article-title":"The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis","volume":"54","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425171834_DKU135C7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1128\/AAC.01133-10","article-title":"Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates","volume":"55","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425171834_DKU135C8","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/jac\/dkq050","article-title":"Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin","volume":"65","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170425171834_DKU135C9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/jac\/42.2.189","article-title":"Glycopeptide tolerance in Staphylococcus aureus","volume":"42","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170425171834_DKU135C10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1128\/AAC.38.3.487","article-title":"Role of tolerance in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis with vancomycin, teicoplanin, and daptomycin","volume":"38","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425171834_DKU135C11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1476-0711-10-26","article-title":"Bactericidal activity of oxacillin and glycopeptides against Staphylococcus aureus in patients with endocarditis: looking for a relationship between tolerance and outcome","volume":"10","year":"2011","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"key\n\t\t\t\t20170425171834_DKU135C12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/1471-2334-11-287","article-title":"Characterization of heterogeneous vancomycin-intermediate resistance, MIC and accessory gene regulator (agr) dysfunction among clinical bloodstream isolates of Staphylococcus aureus","volume":"11","year":"2011","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20170425171834_DKU135C13","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1086\/421092","article-title":"Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy","volume":"38","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425171834_DKU135C14","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1128\/AAC.00939-06","article-title":"Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia","volume":"51","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425171834_DKU135C15","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1128\/AAC.49.7.2687-2692.2005","article-title":"Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function","volume":"49","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425171834_DKU135C16","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1086\/368128","article-title":"Staphylococcus aureus accessory gene regulator (agr) group II: is there a relationship to the development of intermediate-level glycopeptide resistance?","volume":"187","year":"2003","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170425171834_DKU135C17","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1128\/AAC.46.5.1492-1502.2002","article-title":"Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin","volume":"46","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425171834_DKU135C18","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1128\/AAC.00671-06","article-title":"Evaluation of accessory gene regulator (agr) group and function in the proclivity towards vancomycin intermediate resistance in Staphylococcus aureus","volume":"51","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425171834_DKU135C19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0196-6553(88)90053-3","article-title":"CDC definitions for nosocomial infections, 1988","volume":"16","year":"1988","journal-title":"Am J Infect Control"},{"key":"key\n\t\t\t\t20170425171834_DKU135C20","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1128\/AAC.00113-08","article-title":"Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin","volume":"52","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425171834_DKU135C21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","year":"1976","journal-title":"Nephron"},{"key":"key\n\t\t\t\t20170425171834_DKU135C22","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","article-title":"APACHE II: a severity of disease classification system","volume":"13","year":"1985","journal-title":"Crit Care Med"},{"key":"key\n\t\t\t\t20170425171834_DKU135C23","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.jclinepi.2006.01.016","article-title":"Comorbidity risk-adjustment measures were developed and validated for studies of antibiotic-resistant infections","volume":"59","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"key\n\t\t\t\t20170425171834_DKU135C24","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1086\/313650","article-title":"Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia","volume":"30","year":"2000","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425171834_DKU135C25","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1086\/375057","article-title":"Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia","volume":"36","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425171834_DKU135C26","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1001\/archinte.162.19.2229","article-title":"Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus","volume":"162","year":"2002","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20170425171834_DKU135C27","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/313753","article-title":"Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis","volume":"30","year":"2000","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425171834_DKU135C28","volume-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically\u2014Ninth Edition: Approved Standard M07-A9","author":"Clinical and Laboratory Standards Institute","year":"2012"},{"key":"key\n\t\t\t\t20170425171834_DKU135C29","article-title":"Tests to assess bactericidal activity","volume-title":"Clinical Microbiology Procedures Handbook","year":"2004"},{"key":"key\n\t\t\t\t20170425171834_DKU135C30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1128\/JCM.01508-06","article-title":"A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides","volume":"45","year":"2007","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170425171834_DKU135C31","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1128\/JCM.41.11.5113-5120.2003","article-title":"Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database","volume":"41","year":"2003","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170425171834_DKU135C32","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1086\/529190","article-title":"Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia","volume":"46","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425171834_DKU135C33","volume-title":"Recursive Partitioning in the Health Sciences","year":"1999"},{"key":"key\n\t\t\t\t20170425171834_DKU135C34","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/aje\/kwg074","article-title":"Estimating the relative risk in cohort studies and clinical trials of common outcomes","volume":"157","year":"2003","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t20170425171834_DKU135C35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/aje\/kwi188","article-title":"Easy SAS calculations for risk or prevalence ratios and differences","volume":"162","year":"2005","journal-title":"Am J Epidemiol"},{"issue":"Suppl 1","key":"key\n\t\t\t\t20170425171834_DKU135C36","first-page":"S13","article-title":"Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal\/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains","volume":"42","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425171834_DKU135C37","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1001\/archinte.163.17.2066","article-title":"Clinical identifiers of complicated Staphylococcus aureus bacteremia","volume":"163","year":"2003","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20170425171834_DKU135C38","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1128\/AAC.30.5.633","article-title":"Problems in in vitro determination of antibiotic tolerance in clinical isolates","volume":"30","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425171834_DKU135C39","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1128\/AAC.30.4.521","article-title":"Antibiotic tolerance among clinical isolates of bacteria","volume":"30","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425171834_DKU135C40","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/cid\/cis717","article-title":"Methicillin-resistant Staphylococcus aureus (MRSA) staphylococcal cassette chromosome mec genotype effects outcomes of patients with healthcare-associated MRSA bacteremia independently of vancomycin minimum inhibitory concentration","volume":"55","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425171834_DKU135C41","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1128\/AAC.00407-11","article-title":"Predictors of agr dysfunction in methicillin-resistant Staphylococcus aureus (MRSA) isolates among patients with MRSA bloodstream infections","volume":"55","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425171834_DKU135C42","first-page":"5","article-title":"Chapter 2. Causation and causal inference","volume-title":"Modern Epidemiology","year":"2008","edition":"3rd edn."},{"key":"key\n\t\t\t\t20170425171834_DKU135C43","first-page":"309","article-title":"Are vancomycin troughs adequate for optimal dosing?","volume":"58","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425171834_DKU135C44","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/cid\/cir078","article-title":"Vancomycin: we can't get there from here","volume":"52","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425171834_DKU135C45","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/cid\/cir764","article-title":"Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case\u2013control study","volume":"54","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425171834_DKU135C46","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/cid\/cit112","article-title":"Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg\/L: a matched cohort study","volume":"56","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425171834_DKU135C47","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/phar.1220","article-title":"Implementation of an antimicrobial stewardship pathway with daptomycin for optimal treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"33","year":"2013","journal-title":"Pharmacotherapy"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T13:28:04Z","timestamp":1498138084000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dku135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,19]]},"references-count":47,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,5,19]]},"published-print":{"date-parts":[[2014,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dku135","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,19]]}}}